The Kowalinski group at EMBL Grenoble discovered notable differences between the nuclear cap-binding complex in trypanosomes and humans, a critical component in cellular RNA metabolism. Trypanosomes ...

Ranjan Narula, Swati Dalal, and Vanshika Oberoi of RNA, Technology and IP Attorneys explore the legal framework, challenges, ...

The highly anticipated 2025 ASC Student Supercomputer Challenge (ASC25) launch event was held recently in Beijing. The ...

Serum Institute of India is planning to introduce chikungunya and monkeypox vaccines in about a year and a half and a dengue vaccine in approximately three years. The company is focusing on vaccine ...

Researchers analyzed 168,464 samples to uncover how geographic and technical factors shape global gut microbiome variation, highlighting underrepresented regions and technical biases.

DNA-tagged gold nanoparticles Andy Tay 1Asst Prof Andy Tay (right) and Ms Huang Xingyue (left) from NUS have developed a ...

Researchers at the University of Copenhagen and NTU Singapore have discovered that RNA damage, not DNA damage, is the real trigger for the acute effects of sunburn. This new understanding challenges ...

1月22日晚，“灵蛇贺三亚温暖中国年”2025年三亚新春旅游文化系列活动之小年特别活动新春游园会登场，吸引了包括塔蒂亚娜在内的众多俄罗斯游客前来体验“中国年”。塔蒂亚娜说，虽然她已经70岁了，但仍然想参与到现场诸多互动游戏中，“用毛笔写‘福’字，这是 ...

Aro Biotherapeutics, a clinical-stage biotechnology company working to develop potent and tissue-targeted medicines, today announced the dosing of the first patient in its clinical trial of ABX1100, a ...

MRNA’s first problem is the lack of near-term catalysts beyond infectious disease vaccines. The stock often swings on disease outbreaks, such as H5N1 avian flu last year, but this is unlikely to ...

The research teams at LV Prasad Eye Institute under the Centre for Ocular Regeneration (CORE) at the Brien Holden Research Centre, organized the second edition of the ‘Future is Here’.

MaxCyte Inc. (NASDAQ: MXCT) is a global developer of next-generation cell therapies. They provide crucial technology for cell ...